
---
title: '复旦张江：盐酸多柔比星脂质体注射液获得一致性评价受理通知书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=9318'
author: 证券时报网
comments: false
date: Tue, 19 Jul 2022 17:26:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=9318'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688505" style="color: #2f67d1;text-decoration: none;" code="688505" target="_blank">复旦张江</a>(688505)7月19日晚间公告，盐酸多柔比星脂质体注射液获得一致性评价受理通知书。该药物主要用于卡波氏肉瘤、乳腺癌和卵巢癌等肿瘤的治疗。</p>

                  
</div>
            